TCF7L2, a trans-element of the novel XLOC_203003, a high mobility group (HMG) box-containing transcription factor and plays a key role in the WNT signaling pathway response to metabolic disturbances and glucose homeostasis, and the mediation of insulin resistance [72]. This evidence concerns the gene TCF7L2 and Insulin resistance.